Barclays Maintains Underweight on Mandiant, Lowers Price Target to $19

Barclays analyst Saket Kalia maintains Mandiant (NASDAQ:MNDT) with a Underweight and lowers the price target from $20 to $19.

byBenzinga Newsdesk

October 13, 2021

1 minute read

Barclays analyst Saket Kalia maintains Mandiant (NASDAQ:MNDT) with a Underweight and lowers the price target from $20 to $19.

Mid-Afternoon Market Update: Dow Tumbles Over 200 Points; BELLUS Health Shares Spike Higher

By Lisa Levin

Today, 5:59 AM

Toward the end of trading Monday, the Dow traded down 0.67% to 35,728.62 while the NASDAQ fell 0.92% to 15,487.41. The S&P also fell, dropping 0.58% to 4,684.47.

ARNA

News

Turning Point Brands, ReCreation Marketing Earlier Announced That ReCreation Marketing Has Changed Its Name To Turning Point Brands Canada

By Benzinga Newsdesk

Today, 5:59 AM

Turning Point Brands, Inc. ("TPB") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, and

TPB